Quantum Interface, LLC

The Goodyear & Tire Rubber Company

Plx Opco Inc.

Montell Technology Company Bv

Plx Pharma Inc.

Robert W Strozier

Jonathan Josephson

Upendra K Marathi

Shaun Gammill

Susann Childress

Wen-Liang Hsu

Neil Arthur Maly

Dane Kenton Parker

John A Ewen

Richard J Kurr

Lawson G Wideman

Michael J Elder

Barry A Matrana

David Andrew Benko

William Paul Francik

Walter H Waddell

Robert L Jones, Jr

Fredrick Lewis Magnus

Ronald R Zimmerman

Efthymios Deliargyris

Jeffrey W Moore

Zalman Ronen

Jose Cantillo

Apparatuses, systems, interfaces, and implementing methods including constructing training programs or routines and predictive training programs and routines implemented in a VR, AR, MR or XR environments, preparing non-predictive and/or predictive tools for use in predictive and/or non-predictive training programs or routines implemented in the VR/AR/MR/XR environments, converting non-computer assisted training programs into predictive and/or non-predictive training programs implemented in a VR and/or AR/MR/XR environments, and implementing avatars to assist trainees in performing training programs routines or any aspects thereof.

Predictive virtual training systems, apparatuses, interfaces, and methods for implementing same

Small molecule integrin agonists or integrin activating compounds including at least one di-alkylaryl amine end group and at least one alkyl or alkenoxy linking group including at least one protonatable moiety, wherein the compounds enhance vaccine efficacies, enhance adoptive cell therapy efficacies, enhance immunotherapy efficacies, enhance therapeutic antibody therapy efficacies, enhance checkpoint inhibitor therapy efficacies, enhance effector cell therapy efficacies, and enhanced cell based transplant efficacies and wherein at protonatable moiety either protonate at biological pHs or bears a charge with associated pharmaceutically acceptable counterion making the compound water soluble to improve bioavailability and methods for making and using same.

Integrin agonists or activating compounds and methods for making and using same

Systems, apparatuses, interfaces, and methods for implementing the systems, apparatuses, and interfaces include capturing an image, displaying the image on a display devise, scanning and identifying objects and/or attributes associated with the image and/or objects therein, generating a 3D AR environment within the display overlaid on the image, generating a ray pointer for improved interaction with the image and the generated 3D AR environment, where the environment includes virtual constructs corresponding to the image objects and/or attributes, and selecting, activating, animating, and/or manipulating the virtual constructs within the 3D AR environment.

Interfaces, systems and apparatuses for constructing 3D AR environment overlays, and methods for making and using same

Disclosed herein are novel drug carriers including a non-aqueous pH dependent release system and a non-aqueous pH dependent reassembly/assembly and reabsorption/absorption system. The carriers are capable of pH dependent release of biologically active agents and assembly or reassembly when the carrier transitions from a low pH environment, to a high pH environment and back to a low pH environment.

Pharmaceutical carriers capable of pH dependent reconstitution and methods for making and using same

Systems, apparatuses, interfaces, and methods for visualizing time progressions in VR/AR/MR/XR environments, wherein the systems include a processing unit or a processor, a display device, and at least one VR/AR/MR/XR input device, wherein the systems, apparatuses, interfaces, and methods display projects or structures that have tasks, goals, targets, and/or events that have or will occur in a given time sequence along a time line, wherein the systems and methods also display a selection and control object and a temporal direction and speed control object.

Systems, apparatuses, interfaces and implementing methods for displaying and manipulating temporal or sequential objects

Novel drug carriers capable of targeted and/or pH dependent release of biologically active agents into selected pH environments including the gastrointestinal (GI), ophthalmic, urinary, or reproductive tracts. Unexpectedly, carriers including free fatty acids (FFA) are able to deliver biologically active agents to various pH environments. Such targeted delivery is tailorable and useful for active agents that are: (a) injurious to the upper GI tract (esophagus, stomach, and duodenum), (b) acid labile, (c) impermeable/insoluble compounds in GI fluids, (d) susceptible to first pass metabolism, and/or (e) cause stomach irritation, upset, or dyspepsia.

PH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same

Novel drug carriers capable of targeted and/or pH dependent release of biologically active agents into selected pH environments including the gastrointestinal (GI), ophthalmic, urinary, or reproductive tracts. Unexpectedly, carriers including free fatty acids (FFA) are able to deliver biologically active agents to various pH environments. Such targeted delivery is tailorable and useful for active agents that are: (a) injurious to the upper GI tract (esophagus, stomach, and duodenum), (b) acid labile, (c) impermeable/soluble compounds in GI fluids, (d) susceptible to first pass metabolism, and/or (e) cause stomach irritation, upset, or dyspepsia.

An apparatus for producing unique user specific identifiers including capturing user specific biometric data, kinetic data, biokinetic data, kinetic data and biometric data, biokinetic data and biometric data, and kinetic data, biokinetic data and biometric data and generating unique user specific identifiers.

Apparatuses, systems and methods for constructing unique identifiers

pH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same

Growing community of inventors

Houston, TX, United States of America

Robert W Strozier